Hypermarcas Plans Dividend of $0.03 (OTCMKTS:HYPMY)

Hypermarcas (OTCMKTS:HYPMY) announced a dividend on Monday, June 23rd, investing.com reports. Investors of record on Tuesday, July 1st will be paid a dividend of 0.0345 per share on Friday, January 8th. This represents a yield of 2.81%. The ex-dividend date of this dividend is Monday, June 30th.

Hypermarcas Trading Down 5.5%

Shares of OTCMKTS:HYPMY opened at $4.59 on Tuesday. Hypermarcas has a 52-week low of $2.64 and a 52-week high of $5.92. The company has a market capitalization of $2.91 billion, a P/E ratio of 19.13 and a beta of 0.79. The company has a 50-day simple moving average of $4.22 and a 200 day simple moving average of $3.57. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.80 and a current ratio of 1.26.

Hypermarcas (OTCMKTS:HYPMY) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported ($0.04) earnings per share (EPS) for the quarter. The company had revenue of $184.34 million for the quarter. Hypermarcas had a return on equity of 6.95% and a net margin of 12.51%.

Hypermarcas Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.